Share
Journal Information
Issue
Vol. 18. Issue 6.Pages 783-934 (November - December 2019)
Editorial
The lack of guidelines and government policies for regulating nonprescription sale of antibiotics and its medical consequences
Eva Juárez-Hernández, Misael Uribe
Ann Hepatol. 2019;18:783-5
Open access
Opinions
Hepatocellular carcinoma, a unique tumor with a lack of biomarkers
Jose D. Debes, Enrique Carrera, Angelo Z. Mattos, Jhon E. Prieto, Andre Boonstra
Ann Hepatol. 2019;18:786-7
Open access
Concise reviews
Can Prohibitin 1 be a Safeguard against liver disease?
Lei Xia, Yuling Liu, Sujun Zhang, Yurong Yang, Zhigang Zhou, Jian Tu
Ann Hepatol. 2019;18:790-5
Open access
Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis
Guohong-Liu, Qingxi-Zhao, Hongyun-Wei
Ann Hepatol. 2019;18:796-803
Open access
Impact of psychosocial status on liver transplant process
Lucia Golfieri, Stefano Gitto, Ranka Vukotic, Pietro Andreone, Fabio Marra, Maria Cristina Morelli, Matteo Cescon, Silvana Grandi
Ann Hepatol. 2019;18:804-9
Open access
Obesity and liver cancer
Carlo Saitta, Teresa Pollicino, Giovanni Raimondo
Ann Hepatol. 2019;18:810-5
Open access
Original articles
Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure
Érica Araújo Mendes, Denise Regina Bairros de Pilger, Ana Catharina de Seixas Santos Nastri, Fernanda de Mello Malta, Bruno dos Santos Pascoalino, Luiz Augusto Carneiro D’Albuquerque, Andrea Balan, Lucio Holanda Gondim de Freitas, ... João Renato Rebello Pinho
Ann Hepatol. 2019;18:816-24
Open access
miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro
Zongqiang Hu, Li Li, Jianghua Ran, Guang Chu, Hongqiang Gao, Licheng Guo, Jiapeng Chen
Ann Hepatol. 2019;18:825-32
Open access
Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis
Ender Gunes Yegin, Salih S. Durusoy, Filiz Ture Ozdemir, Erdem F. Kombak, Cigdem Ataizi-Celikel, Osman C. Ozdogan
Ann Hepatol. 2019;18:833-40
Open access
Evaluation of prophylactic antibiotic regimens on recurrence and mortality in spontaneous bacterial peritonitis
Shelley S. Glaess, Rebecca L. Attridge, Rebecca L. Brady, Russell T. Attridge
Ann Hepatol. 2019;18:841-8
Open access
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil
Cirley Maria de Oliveira Lobato, Liana Codes, Giovanni Faria Silva, Aécio Flávio Meirelles Souza, Henrique Sérgio Moraes Coelho, Maria Lucia Alves Pedroso, Edison Roberto Parise, Leila Maria Soares Tojal de Barros Lima, ... Members of the Brazilian Real-Life Study about HCV treatment
Ann Hepatol. 2019;18:849-54
Open access
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis
Beatriz Castelló, Victoria Aguilera, M. Teresa Blázquez, Ángel Rubín, María García, Carmen Vinaixa, Salvador Benlloch, Fernando SanJuan, ... Marina Berenguer
Ann Hepatol. 2019;18:855-61
Open access
Infection in cirrhosis: A prospective study
Chandramouli Bhattacharya, Manisha Das-Mondal, Debkishore Gupta, Ajoy K. Sarkar, Sujit Kar-Purkayastha, Asokananda Konar
Ann Hepatol. 2019;18:862-8
Open access
Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4
Xiaolin Wei, Hui Liu, Xiaowu Li, Xiangde Liu
Ann Hepatol. 2019;18:869-78
Open access
Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis
Aurora Marina Loaeza-del Castillo, Alhely Gaytán-Santillán, Alma López-Tello, Merit Valdés-Almanza Merit, María del Pilar Milke-García, Jorge Flores-Rodríguez, Ulices Alvirde-García
Ann Hepatol. 2019;18:879-82
Open access
The regulatory role of microRNA-mRNA co-expression in hepatitis B virus-associated acute liver failure
Kanda Pan, Yunchao Wang, Ping Pan, Guanhua Xu, Lujiao Mo, Lijia Cao, Channi Wu, Xiaoyuan Shen
Ann Hepatol. 2019;18:883-92
Highlights
- •
HBV-associated ALF induced 43 DEmiRNAs and 523 DEGs.
- •
Upregulated DEGs were associated with immune and inflammation responses.
- •
Downregulated DEGs were related to metabolism and detoxication.
Open access
Associations between body mass index and mortality in acute-on-chronic liver failure patients
Ruimin Lai, Tianbin Chen, Zimu Wu, Su Lin, Yueyong Zhu
Ann Hepatol. 2019;18:893-7
Open access
Effect of laparoscopic splenectomy on portal vein thrombosis and serum YKL-40 in patients with cirrhotic portal hypertension
Ruizhao Qi, Xin Jin, Haida Shi, Chengfang Wang, Huixing Li, Xianjie Shi
Ann Hepatol. 2019;18:898-901
Open access
A simple scoring model for predicting early graft failure and postoperative mortality after liver transplantation
Rafael Diaz-Nieto, Panagis Lykoudis, Francis Robertson, Dinesh Sharma, Kevin Moore, Massimo Malago, Brian R. Davidson
Ann Hepatol. 2019;18:902-12
Open access
Alcohol and HBV synergistically promote hepatic steatosis
Zhan-Ming Li, Chao-Yue Kong, Shi-Long Zhang, Bing Han, Zheng-Yan Zhang, Li-Shun Wang
Ann Hepatol. 2019;18:913-7
Open access
The GLP-1 analog liraglutide attenuates acute liver injury in mice
Letícia Milani, Claudia M. Galindo, Natalia Mulinari Turin de Oliveira, Claudia Rita Corso, Eliana Rezende Adami, Maria Carolina Stipp, Olair Carlos Beltrame, Alexandra Acco
Ann Hepatol. 2019;18:918-28
Open access
Case report
Metastatic cholangiocarcinoma in a patient with undiagnosed Wilson disease
Marianna G. Mavilia, Aniket Sharma, Faripour Forouhar
Ann Hepatol. 2019;18:929-31
Open access
News
An acknowledgement
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
